ImmuPharma PLC (IMM) - Cash Flow Conversion Efficiency

Latest as of June 2025: -2.979x

Based on the latest financial reports, ImmuPharma PLC (IMM) has a cash flow conversion efficiency ratio of -2.979x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (GBX-1.00 Million ≈ $-122.04 USD) by net assets (GBX336.70K ≈ $40.97 USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see IMM market cap for the company's overall valuation and market capitalisation.

ImmuPharma PLC - Cash Flow Conversion Efficiency Trend (2004–2024)

This chart illustrates how ImmuPharma PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ImmuPharma PLC Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ImmuPharma PLC ranked by their cash flow conversion efficiency. Explore cash flow quality index of ImmuPharma PLC to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
GO METALS CORP. F:47GA	-0.165x
Ellwee AB ST:ELLWEE	0.503x
Capital Metals PLC LSE:CMET	-0.094x
Rajvir Industries Limited NSE:RAJVIR	-0.158x
VOLTAGE METALS CORP. F:8L10	0.064x
Chimeric Therapeutics Ltd AU:CHM	1.268x
EV Digital Invest AG F:ENGL	N/A
Cannassure Therapeutics Ltd TA:CSURE	N/A

Annual Cash Flow Conversion Efficiency for ImmuPharma PLC (2004–2024)

The table below shows the annual cash flow conversion efficiency of ImmuPharma PLC from 2004 to 2024. View IMM share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	GBX-542.86K ≈ $-66.05	GBX-1.77 Million ≈ $-215.25	3.259x	+352.29%
2023-12-31	GBX1.06 Million ≈ $128.52	GBX-1.36 Million ≈ $-166.01	-1.292x	-38.87%
2022-12-31	GBX2.52 Million ≈ $307.02	GBX-2.35 Million ≈ $-285.57	-0.930x	+15.06%
2021-12-31	GBX4.41 Million ≈ $536.99	GBX-4.83 Million ≈ $-588.06	-1.095x	-217.56%
2020-12-31	GBX9.65 Million ≈ $1.17K	GBX-3.33 Million ≈ $-405.09	-0.345x	+56.96%
2019-12-31	GBX5.27 Million ≈ $641.11	GBX-4.22 Million ≈ $-513.62	-0.801x	-29.36%
2018-12-31	GBX7.62 Million ≈ $927.50	GBX-4.72 Million ≈ $-574.43	-0.619x	+49.93%
2017-12-31	GBX3.57 Million ≈ $434.91	GBX-4.42 Million ≈ $-537.91	-1.237x	-5.76%
2016-12-31	GBX5.55 Million ≈ $674.79	GBX-6.49 Million ≈ $-789.17	-1.170x	+52.34%
2015-12-31	GBX1.69 Million ≈ $205.67	GBX-4.15 Million ≈ $-504.74	-2.454x	-462.18%
2014-12-31	GBX5.71 Million ≈ $694.18	GBX-2.49 Million ≈ $-303.03	-0.437x	+39.73%
2013-12-31	GBX5.40 Million ≈ $657.48	GBX-3.91 Million ≈ $-476.20	-0.724x	-87.19%
2012-12-31	GBX8.42 Million ≈ $1.02K	GBX-3.26 Million ≈ $-396.30	-0.387x	-43.72%
2011-12-31	GBX12.51 Million ≈ $1.52K	GBX-3.37 Million ≈ $-409.67	-0.269x	+37.19%
2010-12-31	GBX15.97 Million ≈ $1.94K	GBX-6.84 Million ≈ $-832.84	-0.429x	-164.78%
2009-12-31	GBX18.08 Million ≈ $2.20K	GBX11.96 Million ≈ $1.46K	0.662x	+389.02%
2008-12-31	GBX11.24 Million ≈ $1.37K	GBX-2.57 Million ≈ $-313.06	-0.229x	+80.78%
2007-12-31	GBX3.05 Million ≈ $371.10	GBX-3.63 Million ≈ $-441.91	-1.191x	-239.23%
2006-03-31	GBX2.50 Million ≈ $304.66	GBX-879.00K ≈ $-106.95	-0.351x	-1391.04%
2005-03-31	GBX993.00K ≈ $120.82	GBX27.00K ≈ $3.29	0.027x	+2559.21%
2004-03-31	GBX978.00K ≈ $118.99	GBX1.00K ≈ $0.12	0.001x	--

About ImmuPharma PLC

LSE:IMM UK Biotechnology

Market Cap

$223.87K

GBX1.84 Billion GBX

Market Cap Rank

#31314 Global

#1021 in UK

Share Price

GBX3.66

Change (1 day)

-3.81%

52-Week Range

GBX3.21 - GBX13.00

All Time High

GBX190.00